Kevin Howe
Senior VP of Strategic OperationsMr. Kevin Howe, BPharm, PhD, serves as Senior Vice President of Strategic Operations at Biora Therapeutics, Inc. (formerly known as Progenity, Inc.) He has over 30 years of experience in the industry. Kevin was the founder of Epi-Cure Consulting Ltd, a specialist drug development and regulatory organization and QP service provider. He worked with the National Health Service, the pharmaceutical industry and Quintiles where he was head of the Pharma Consulting Group in Europe. During his career, he has worked with the full range of products from synthetic NCEs to biologics, naturally derived and biotechnology, as well as genetically modified human cell vaccines, alone and in combination with devices. His educational background includes a BPharm and PhD in altered protein states from Chelsea College, University of London.
Positions
- Company NameBiora Therapeutics, Inc.Stock CodeBIORQPositionSenior VP of Strategic OperationsColleagues
- APAditya P. MohantyCEO & Director
- JDJeffrey Donald AlterIndependent Chairman
- CNClarke NeumannSenior VP, General Counsel & Secretary
- PSPaul ShabramHead of Technical Operations
- JKJames KnightHead of Business Development
- BLBrian L. KotzinIndependent Director
- BEBruce E. SandsChairman of Inflammatory Bowel Disease Clinical Advisory Board
- JAJill Ann HoweIndependent Director
